Patents by Inventor Thomas M Engber

Thomas M Engber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of Conditions Involving Dopaminergic Neuronal Degeneration Using Nogo Receptor Antagonists
    Publication number: 20080045926
    Abstract: The invention provides methods for promoting regeneration or survival of dopaminergic neurons in a mammal displaying signs or symptoms of dopaminergic neuronal degeneration, including a human with Parkinson's disease, using Nogo receptor antagonists.
    Type: Application
    Filed: January 28, 2005
    Publication date: February 21, 2008
    Inventors: Jane K. Relton, Thomas M. Engber
  • Use of K-252a derivative
    Patent number: 6184217
    Abstract: Disclosed herein are therapeutic methologies utilizing a ring substituted derivative of the indolocarbazole K-252a, the derivative represented by the formula:
    Type: Grant
    Filed: June 24, 1997
    Date of Patent: February 6, 2001
    Assignee: Cephalon, Inc.
    Inventors: Thomas M Engber, Forrest A. Haun, Michael S. Saporito, Lisa D. Aimone, Matthew S. Miller, Ernest Knight, Jr.